Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    12039422 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Isradipine CR 5mg;   Drug: Isradipine CR 10mg;   Drug: Isradipine CR 20mg;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.